Home Newsfeeds Wedbush Maintains Neutral on Apellis Pharmaceuticals, Raises Price Target to $67

Wedbush Maintains Neutral on Apellis Pharmaceuticals, Raises Price Target to $67

Wedbush analyst Laura Chico maintains Apellis Pharmaceuticals (NASDAQ:APLS) with a Neutral and raises the price target from $55 to $67.

byBenzinga Newsdesk

September 12, 2022

1 minute read

Wedbush analyst Laura Chico maintains Apellis Pharmaceuticals (NASDAQ:APLS) with a Neutral and raises the price target from $55 to $67.

Biden Administration Greenlights Samsung and SK Hynix’s Expansion in China Despite Prevailing Restrictions

By Anusuya Lahiri

October 9, 11:40 AM

The Biden administration has granted Samsung Electronics Co (OTC: SSNLF) and SK Hynix Inc, the world's two largest memory makers, permission to acquire the equipment essential for maintaining and expanding their significant

AAPL

‘UBS Agrees To Buy Credit Suisse For More Than $2B’ – Financial Times

By Happy Mohamed

March 19, 1:48 PM

https://www.ft.com/content/ec4be743-052a-4381-a923-c2fbd7ea9cfd Please use the sharing tools found via the share button at the top or side of articles. Copying articles to share with others is a breach of FT.com

Nasdaq Down 50 Points; ConocoPhillips Posts Upbeat Earnings

By Lisa Levin

May 4, 3:16 PM

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping over 300 points on Thursday. The Dow traded down 1.19% to 33,015.85 while the NASDAQ fell 0.49% to 11,966.96. The S&P 500, also fell, dropping, 0.80% to 4,058.14.

ASNS

Why Tesla Stock Is Higher In Pre-Market Today After 5-Session Losing Streak

By Shanthi Rexaline

December 23, 7:30 AM

Tesla Inc. (NASDAQ: TSLA) shares appear to have stemmed the slide on Friday. What Happened: After the 64.4% plunge thus far this year, the stock advanced 1.79% to $127.60 in premarket trading on Friday.

TSLA

Wedbush Maintains Neutral on Apellis Pharmaceuticals, Raises Price Target to $67

Related Posts

Biden Administration Greenlights Samsung and SK Hynix’s Expansion in China Despite Prevailing Restrictions

‘UBS Agrees To Buy Credit Suisse For More Than $2B’ – Financial Times

Nasdaq Down 50 Points; ConocoPhillips Posts Upbeat Earnings

Why Tesla Stock Is Higher In Pre-Market Today After 5-Session Losing Streak